Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06172140
Other study ID # SYSKY-2023-1091-02
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date September 1, 2025

Study information

Verified date December 2023
Source Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Contact Ganglan Fu, PhD
Phone 13570275074
Email fugangl@mail.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Eligible patients undergoing hysteroscopy were randomly assigned in a 1:1 ratio to receive intravenous anesthesia with either propofol (2 mg/kg) or remifentanil (0.4 mg/kg).Continuous monitoring of pulse oximetry (SpO2), blood pressure (BP), heart rate (HR), expired gas partial pressure of carbon dioxide, integrated respiratory index (IPI), tidal volume (TV), respiratory rate (RR), and minute ventilation (MV) was performed.During induction, the MOAA/S score was assessed every 30 seconds. If the MOAA/S score remained >1, a supplementary dose of 1/2 of the initial dose was injected within 10 seconds.If more than 5 supplementary doses were required within 15 minutes, it was considered that the painless hysteroscopy failed and propofol was used to enhance sedation.Continuous oxygen administration at a flow rate of 5 liters per minute was provided through nasal catheters until the patient was fully alert with a MOAA/S score of 5 and vital signs were stable.Observation indicators included: (1) the success rate of hysteroscopy;(2) induction time (MOAA/S ≤ 1 after the first dose);(3) full recovery time of consciousness;(4) operation duration;(5) number of additional anesthetics;(6) incidence of hypotension, hypoxemia, sinus bradycardia, delayed recovery, and injection pain;(7) respiratory parameters and minimum SpO2, IPI values before anesthesia, after induction, and after awakening.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 124
Est. completion date September 1, 2025
Est. primary completion date March 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Voluntary signing of informed consent form - Stable vital signs and qualified anesthesia outpatient evaluation - No contraindications to anesthesia Exclusion Criteria: - Not willing to sign informed consent form - Anaesthesia drug allergy - Severe central nervous system diseases - Severe hypertension and diabetes - Mental disorders - History of using psychotropic drugs in the past 3 months

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ciprofol group
All patients received 5 µ g of sufentanil 1 minute before intravenous infusion of ciprofol, followed by intravenous injection of ciprofol (0.4mg/kg). When the MOAA/S score is = 1, vaginal disinfection begins. During the induction of sedation, the MOAA/S score is evaluated every 30 seconds. If the MOAA/S score remains above 1, a supplementary dose of 1/2 of the initial dose is injected within 10 seconds. During the maintenance phase, supplementary doses are given when there are signs of physical activity, eye opening, or speech. If more than 5 additional doses are required within 15 minutes, painless hysteroscopy is considered a failure, and propofol is immediately used to enhance sedation.
Propofol group
All patients received 5 µ g of sufentanil 1 minute before intravenous infusion of propofol, followed by intravenous injection of propofol (2 mg/kg) for 30 seconds. When the MOAA/S score is = 1, vaginal disinfection begins. During the induction of sedation, the MOAA/S score is evaluated every 30 seconds. If the MOAA/S score remains above 1, a supplementary dose of 1/2 of the initial dose is injected within 10 seconds. During the maintenance phase, supplementary doses are given when there are signs of physical activity, eye opening, or speech. If more than 5 additional doses are required within 15 minutes, painless hysteroscopy is considered a failure, and propofol is immediately used to enhance sedation.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Outcome

Type Measure Description Time frame Safety issue
Primary Success rate of painless hysteroscopy During the induction of sedation, the anaesthesiologist evaluated the MOAA/S score every 30 s. If the MOAA/S score remained >1 after 2 min of initial administration of the study drug, a top-up dose of 1/2 the initial dose was injected over 10 s. During the maintenance phase, supplementary doses are given when the MOAA/S score is>1, and repeated every 2 minutes as needed. If more than 5 additional doses are required within 15 minutes, it is considered a failure of painless hysteroscopy . During procedure (The inspection is completed and the vaginal speculum is removed)
See also
  Status Clinical Trial Phase
Completed NCT05514236 - Effect of Virtual Reality and Music Therapy on Pain Relief in Outpatient Hysteroscopy N/A
Completed NCT06092541 - Pericervical Analgesia Versus Analesia With Nitrous Oxide (N2O) in Outpatien Operative Hysteroscopy With Miniresector N/A
Not yet recruiting NCT05069077 - the Effect of Music on Pain and Women Satisfaction During Diagnostic Outpatient Hysteroscopy in Postmenopausal Women N/A
Completed NCT03701984 - The Effect of Intrauterine Lidocaine Infusion and Oral Tramadol on Pain During Diagnostic Office Hysteroscopy Phase 4
Not yet recruiting NCT05069025 - Use of Music in Reducing Pain During Outpatient Hysteroscopy in Primarily Infertile Patients N/A
Completed NCT04166500 - Early Outpatient Hysteroscopy Can Prevent Intrauterine Adhesion After Induced Abortion N/A
Not yet recruiting NCT06379841 - Green Hysteroscopy N/A
Completed NCT02863679 - Postoperative Analgesic Efficacy of Tetracaine Hydrochloride Gel N/A
Completed NCT02142673 - The Impact of Different Filling Pressures in Operative Outpatient Hysteroscopy on the Procedure Success Rates and Associated Pain. N/A
Completed NCT02142686 - Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy N/A
Completed NCT05540379 - Role of Virtual Reality Simulators in Basic Hysteroscopy Training Competence N/A
Completed NCT04462835 - Feasibility, Effectiveness and Safety of Outpatient Hysteroscopy
Recruiting NCT04862598 - Virtual Reality to Improve Satisfaction in Hysteroscopy Patients N/A
Recruiting NCT01376934 - Clinical Trial of Hysteroscopy in Postmenopausal Women to Compare Techniques N/A
Recruiting NCT03409835 - Effect of Ramosetron on Post-discharge Nausea and Vomiting N/A
Enrolling by invitation NCT03579550 - Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus N/A
Recruiting NCT02736071 - Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy Phase 3
Recruiting NCT02736019 - Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women Phase 3
Not yet recruiting NCT05858931 - Hysteroscopic Evaluation and the Clinical Outcomes of Vaginal Repair of Cesarean Section Scar Defects
Completed NCT04232930 - The Use of Music in Reducing Pain During Outpatient Hysteroscopy N/A